MedPath

北京天衡药物研究院南阳天衡制药厂

Ownership
-
Established
2002-03-25
Employees
-
Market Cap
-
Website
www.nythpharm.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20244984
Approval Date
Sep 26, 2024
NMPA

Telmisartan Tablets

Product Name
替米沙坦片
Approval Number
国药准字H20227111
Approval Date
Aug 31, 2022
NMPA

Risperidone Tablets

Product Name
敬平
Approval Number
国药准字H20061072
Approval Date
Sep 4, 2020
NMPA

Levocetirizine Dihydrochloride Tablets

Product Name
盐酸左西替利嗪片
Approval Number
国药准字H20060677
Approval Date
Sep 4, 2020
NMPA

Telmisartan Tablets

Product Name
沙泰齐
Approval Number
国药准字H20060669
Approval Date
Sep 4, 2020
NMPA

Olanzapine Tablets

Product Name
奥氮平片
Approval Number
国药准字H20203413
Approval Date
Aug 12, 2020
NMPA

Olanzapine Tablets

Product Name
奥氮平片
Approval Number
国药准字H20203414
Approval Date
Aug 12, 2020
NMPA

GLipizide Tablets

Product Name
格列吡嗪片
Approval Number
国药准字H19983109
Approval Date
Mar 17, 2020
NMPA

Dextromethorphan　Hydrobromide　Tablets

Product Name
氢溴酸右美沙芬片
Approval Number
国药准字H19994088
Approval Date
Mar 17, 2020
NMPA

Nimodipine Capsules

Product Name
尼莫地平胶囊
Approval Number
国药准字H19993552
Approval Date
Mar 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy